Sarepta Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Sarepta Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2024.
  • Sarepta Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 100M shares, a 13% increase year-over-year.
  • Sarepta Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 92.4M shares, a 5.53% increase from 2022.
  • Sarepta Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 87.6M shares, a 7.75% increase from 2021.
  • Sarepta Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 81.3M shares, a 4.24% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 100M +11.6M +13% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 99.1M +10.4M +11.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 99.1M +10.9M +12.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 92.4M +4.84M +5.53% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 88.9M +1.26M +1.44% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 88.7M +1.23M +1.41% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 88.2M +933K +1.07% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 87.6M +6.3M +7.75% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 87.6M +7.75M +9.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 87.5M +7.77M +9.74% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 87.3M +7.8M +9.82% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 81.3M +3.31M +4.24% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 79.9M +1.38M +1.76% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 79.7M +1.78M +2.28% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 79.5M +3.02M +3.95% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 78M +4.34M +5.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 78.5M +4.32M +5.83% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 78M +4.01M +5.42% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 76.4M +4.7M +6.55% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 73.6M +7.37M +11.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 74.2M +7.97M +12% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 74M +8.47M +12.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 71.7M +7.1M +11% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 66.3M +1.97M +3.07% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 66.2M +4.95M +8.08% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 65.5M +10.5M +19.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 64.6M +8.62M +15.4% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-03
Q4 2017 64.3M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 61.3M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 55M +8.82M +19.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 56M +10.3M +22.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q2 2016 46.2M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 45.7M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2012 26.3M +3.69M +16.3% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-03
Q3 2012 22.8M +201K +0.89% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-03
Q2 2012 22.7M -495K -2.14% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-03
Q1 2012 22.6M +2.41M +11.9% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-03
Q4 2011 22.6M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 22.6M Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 23.2M -87.2M -79% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 20.2M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q2 2010 110M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.